viewW.W. Grainger

WW Grainger Q3 earnings beat estimates, ups full-year profit outlook


WW Grainger's (NYSE:GWW) third-quarter profit Tuesday beat estimates for the sixth straight quarter as the industrial maintenance and safety products supplier raised its full-year earnings outlook.

For the three months that ended September 30, the company posted earnings of $182.1 million, or $2.51 per share, on revenue of $2.1 billion.

On an adjusted basis, the company earned $2.44 per share, while the market expected earnings of $2.33 a share, on sales of $2.1 billion.

Grainger's chairman, president and CEO, Jim Ryan, said: "This was an exceptional quarter for Grainger. We saw consistent, double-digit, sales growth each month of the quarter and delivered strong earnings growth and cash flow."

The company, considered an industrial bellwether, raised its full-year profit outlook to $8.80-$9.00 per share, from its earlier forecast of $8.40-$8.70 per share. It expects revenue growth of 11-12%, up from prior view of 9-10% driven by its $344 million Fabory Group acquisition in August.

For the full year, analysts are expecting earnings of $8.76 per share, on sales of $8 billion.

WW Grainger competes with MSC Industrial Direct and Fastenal, which last week reported third-quarter profit in-line with estimates.

Shares of the Chicago-headquartered company were up 2% to $158.19 Tuesday morning.

Quick facts: W.W. Grainger

Price: 350.11 USD

Market: NYSE
Market Cap: $18.79 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Quadrise Fuels International completes industrial pilot for alternative fuel...

Quadrise Fuels International PLC's (LON:QFI) Mike Kirk and Jason Miles talk to Proactive's London's Katie Pilbeam about the completion of their alternative fuel trial, MSAR, at an international chemical group customer’s plant in Morocco. Kirk explains the potential and opportunities for their...

18 hours, 9 minutes ago

2 min read